OPT - Afternoon delight on this biotech.2.11pm and 2.13pm trades superb.2 - 3 billion in annual expected revenues if their eye treatment gets up .Source AFR Pengana Capital.
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
